| DC Field | Value | Language |
|---|
| dc.contributor.author | Kovalenko, S. M. | - |
| dc.contributor.author | Konovalova, I. S. | - |
| dc.contributor.author | Merzlikin, S. I. | - |
| dc.contributor.author | Chuev, V. P. | - |
| dc.contributor.author | Kravchenko, D. V. | - |
| dc.date.accessioned | 2021-06-29T09:01:33Z | - |
| dc.date.available | 2021-06-29T09:01:33Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient / S.M. Kovalenko [et al.] // Acta Crystallographica Section E: Crystallographic Communications. - 2020. - Vol.76.-P. 1407-1411. - Doi: 10.1107/S2056989020010439. - Refer.: p. 1410-1411. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/42530 | - |
| dc.description.abstract | The chiral title compound, C₁₆H₂₀N₂O₂, which can be used for producing active pharmaceutical ingredients for treatment of type 2 pancreatic diabetes and other pathologies dependent on insulin resistance, was prepared from (1R,3S) - camphoric acid and o-phenylenediamine | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacy | ru |
| dc.subject | crystal structure | ru |
| dc.subject | Hirshfeld surface | ru |
| dc.subject | active pharmaceutical ingredient | ru |
| dc.subject | anti-diabetic agents | ru |
| dc.subject | type 2 diabetes | ru |
| dc.title | (1 R,3 S)-3-(1 H -Benzo[ d ]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
